Gene Therapy for Glioblastoma Shows Promise in Phase 1 Trial
Brigham and Women's Hospital
In a first-in-human trial in patients with recurrent glioblastoma, an oncolytic virus treatment safely extended survival
Researchers note prevalent work overload, burnout, and intent to leave among nurses, clinical staff, and nonclinical staff